Created On
Updated On
The CHA₂DS₂-VASc Score Calculator is a tool designed to assess the risk of stroke in patients with atrial fibrillation (AF). The score is derived from a range of clinical factors, including congestive heart failure, hypertension, age, diabetes, stroke/transient ischemic attack (TIA), vascular disease, and sex category. Each factor is assigned a certain number of points, which are tallied to provide an overall score that correlates with the risk of future stroke in patients with AF.

More details

Use Cases Limitations Evidence Owner's Insight

The app can be used by healthcare professionals, including cardiologists, primary care physicians, and other specialists managing patients with atrial fibrillation. It is particularly useful in making decisions regarding the initiation of anticoagulant therapy to prevent stroke. The app aids in stratifying patients into different risk categories, thereby facilitating personalized patient care.

While the CHA₂DS₂-VASc score is a robust predictor of stroke risk, it does have limitations. It does not account for all possible risk factors for stroke in AF patients, and the predictive value for bleeding risk is not included in the score. The score should be used as a guide in conjunction with clinical judgment.

The development and validation of the CHA₂DS₂-VASc score are grounded in extensive clinical research, including large cohort studies and analyses of nationwide patient databases. The evidence suggests that the score effectively stratifies patients by their risk of stroke, with higher scores correlating with greater risk.

The CHA₂DS₂-VASc Score app is designed to enhance clinical decision-making through evidence-based tools. By translating complex clinical data into a streamlined scoring system, we aim to support healthcare professionals in identifying atrial fibrillation patients at risk for stroke more accurately and rapidly. The app is designed with the clinician's workflow in mind, fostering ease of use and integration into routine patient assessments.

We acknowledge that while the CHA₂DS₂-VASc score is a powerful tool, it is not a substitute for clinical expertise. It should be used as an adjunct to, not a replacement for, comprehensive patient evaluation and personalized risk assessment. The app's utility lies in its ability to consolidate critical patient data and present it in a way that informs, rather than dictates, treatment strategies.

Ultimately, our vision is to empower clinicians to make more informed decisions that lead to better patient outcomes. We believe that by providing a reliable, user-friendly tool, we can contribute to the optimization of stroke prevention strategies in atrial fibrillation, thereby improving the quality of life for patients around the globe.

Your insights and feedback on this app are greatly appreciated. If you have any thoughts or feedback about the app, please leave a comment below.

Peer reviewed

Warning: This application or model has been peer reviewed, but still may occasionally produce unsafe outputs.

  • Favorites: 2
  • Executions: 100

  • Clinical Informatics


Mitchell Parker

Member since